Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients.
about
Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.Cardiovascular determinants of prognosis in normotensive hemodialysis patientsThe interplay between CKD, sudden cardiac death, and ventricular arrhythmiasPredicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry.Diastolic dysfunction is an independent predictor of cardiovascular events in incident dialysis patients with preserved systolic functionHigh-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease.Associations between kidney function and subclinical cardiac abnormalities in CKD.Habitual physical activity measured by accelerometer and survival in maintenance hemodialysis patients.A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC studyEchocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis.Cardiac imaging in patients with chronic kidney disease.Sudden Cardiac Death Among Hemodialysis Patients.Rate of ankle-brachial index decline predicts cardiovascular mortality in hemodialysis patients.Influence of hemodialysis duration on mid-term clinical outcomes in hemodialysis patients with coronary artery disease after drug-eluting stent implantation.Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.Value of Excess Pressure Integral for Predicting 15-Year All-Cause and Cardiovascular Mortalities in End-Stage Renal Disease Patients.Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.Global longitudinal strain is an independent predictor of cardiovascular events in patients with maintenance hemodialysis: a prospective study using three-dimensional speckle tracking echocardiography.Speckle tracking determination of mitral tissue annular displacement: comparison with strain and ejection fraction, and association with outcomes in haemodialysis patients.Association of echocardiographic parameters with mortality in hospitalized patients with lupus nephritis.Systemic haemodynamics in haemodialysis: intradialytic changes and prognostic significance.Treatment of symptomatic coronary artery disease in patients with end-stage renal disease on hemodialysis with paclitaxel-eluting TAXUS stent.
P2860
Q30234797-52AA1851-195F-4EED-AB5E-7220CCE9B828Q31096132-D3FC8592-8F45-4D2A-B38C-9413663334D4Q34629381-8E62F53D-9923-48D2-A7DD-D36B21260B39Q35000643-B4B191BF-3CD7-42CB-9D9B-F2A2BC8E22FFQ35147914-3A4F68EF-BB63-4AA6-849C-6381C839E834Q35228547-EDCC214E-ED74-4E49-90DA-DEC6CD5DFCAEQ35610795-AB81CAFF-ADB5-46CE-982B-D6DC0A5E51C4Q36280359-09FB852E-9ED6-483C-89A2-9C840793DDF7Q36443233-AB12D2F8-5287-4918-99AC-5E846FE0E777Q36652810-2517C7C4-5605-4751-98CA-07B7B39560B2Q36678949-84519B30-2102-4CD6-9881-8C4E264DF4ECQ38308363-2AB535D8-AEF9-46D8-8C95-D341C97615E6Q39145628-DB33583A-6C52-47F9-B64F-3AF4D5CC07D5Q44174277-1F2365A4-3CBF-4137-B95E-9B6A84A73A02Q44532892-29238792-1618-4839-9718-3F56706E5A91Q47441254-17943888-9E1A-4306-96B7-2AA4351000FDQ47571479-391C9288-979B-4DD7-8B35-B73B72DBF98DQ47980746-4513D6B5-E339-4387-BA89-344C0C497E91Q48262190-BAE19C49-B8B8-4AFB-B831-A138062BBD18Q48604242-A7E368D3-383A-47DE-922B-1C0E42BD7FECQ51603249-B862ED5C-E21E-4FA1-A509-7074A49BB34EQ51733380-3B2A4116-1D91-4408-9903-0B423371EAF5Q53347229-89097B5A-27CC-4565-8BD5-44B572B4166E
P2860
Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Prognostic value of reduced le ...... -stage renal disease patients.
@ast
Prognostic value of reduced le ...... -stage renal disease patients.
@en
Prognostic value of reduced le ...... -stage renal disease patients.
@nl
type
label
Prognostic value of reduced le ...... -stage renal disease patients.
@ast
Prognostic value of reduced le ...... -stage renal disease patients.
@en
Prognostic value of reduced le ...... -stage renal disease patients.
@nl
prefLabel
Prognostic value of reduced le ...... -stage renal disease patients.
@ast
Prognostic value of reduced le ...... -stage renal disease patients.
@en
Prognostic value of reduced le ...... -stage renal disease patients.
@nl
P2093
P2860
P356
P1476
Prognostic value of reduced le ...... -stage renal disease patients.
@en
P2093
Hideki Ishii
Hideki Kamiya
Hiroshi Takahashi
Hirotake Kasuga
Keiko Kimura
Mutsuharu Hayashi
Ryo Takahashi
Seiichi Matsuo
Shigeki Yamada
Shoichi Maruyama
P2860
P304
P356
10.2215/CJN.00050110
P577
2010-07-01T00:00:00Z